We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Stem Cells May Repair Injured Heart Muscle

By Biotechdaily staff writers
Posted on 20 May 2002
An animal study suggests that transplanting embryonic stem cells can help repair injured heart muscle and improve cardiac function following heart attacks and congestive heart failure (CHF). More...
The study was conducted by researchers at Beth Israel Deaconess Medical Center (BIDMC, Boston, MA, USA).

CHF is caused by the destruction of cardiomyocytes during a heart attack, resulting in ventricular dysfunction. The study was designed to determine whether implanted embryonic stem cells could survive in injured heart muscle and improve function. One of the advantages in using embryonic stem cells over other cells is to reduce immunoreactivity. The researchers surgically induced a heart attack in two groups of rats, one treated with a culture of embryonic stem mouse cells and one with a sham culture. Injections of stem cells were made at three separate sites in the heart, one on the place the attack took place and two in the heart muscle bordering the area.

Six weeks later, the researchers found that heart attack damage was reduced in the animals implanted with the stem cells. This group also showed significant improvement in left ventricular function. Animals in the control group did not show any improvement. Calculations revealed that the number of marked cells had successfully replicated, with 7.3% growth in the number of enzymatically isolated single cardiomyocytes. The cells were also rod-shaped with clear striations that mimicked heart muscle cells.

"These data strongly suggest that cardiogenesis, or growth of new cardiomyocytes, occurred in the damaged heart muscle following embryonic stem cell transplantation,” said Dr. Yong Fu Xiao, department of cardiology at BIDMC.




Related Links:
Beth Israel Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.